98 related articles for article (PubMed ID: 7478429)
21. A region close to Tp53 shows LOH in familial breast cancer.
Luo L; Chen J; Du Q; Dumanski J; Blennow E; Kockum I; Luthman H; Lindblom A
Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537
[TBL] [Abstract][Full Text] [Related]
22. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
[TBL] [Abstract][Full Text] [Related]
27. [Detection of genetic alterations in sporadic breast tumors].
Schmutzler RK; Homann A; Bierhoff E; Wiestler OD; von Daimling A; Krebs D
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():63-7. PubMed ID: 8672929
[TBL] [Abstract][Full Text] [Related]
28. High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content.
Huiping C; Eiriksdottir G; Sigurdsson A; Sigurgeirsdottir JR; Barkardottir RB; Egilsson V; Ingvarsson S
Anticancer Res; 1998; 18(2A):1031-6. PubMed ID: 9615760
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.
Gudmundsson J; Barkardottir RB; Eiriksdottir G; Baldursson T; Arason A; Egilsson V; Ingvarsson S
Br J Cancer; 1995 Sep; 72(3):696-701. PubMed ID: 7669583
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.
Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS
Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526
[TBL] [Abstract][Full Text] [Related]
31. Lower frequency of allele loss on chromosome 18q in human breast cancer than in colorectal tumors.
Schenk M; Leib-Mösch C; Schenck IU; Jaenicke M; Indraccolo S; Saeger HD; Dallenbach-Hellweg G; Hehlmann R
J Mol Med (Berl); 1996 Mar; 74(3):155-9. PubMed ID: 8846166
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.
Noviello C; Courjal F; Theillet C
Clin Cancer Res; 1996 Sep; 2(9):1601-6. PubMed ID: 9816339
[TBL] [Abstract][Full Text] [Related]
34. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma.
Devilee P; van den Broek M; Kuipers-Dijkshoorn N; Kolluri R; Khan PM; Pearson PL; Cornelisse CJ
Genomics; 1989 Oct; 5(3):554-60. PubMed ID: 2575586
[TBL] [Abstract][Full Text] [Related]
35. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
Tran YK; Newsham IF
Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
[TBL] [Abstract][Full Text] [Related]
36. Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma.
Schmutzler RK; Bierhoff E; Werkhausen T; Fimmers R; Speiser P; Kubista E; Krebs D; Zeillinger R; Wiestler OD; Von Deimling A
Int J Cancer; 1997 Jun; 74(3):322-5. PubMed ID: 9221812
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity at D14S62 and metastatic potential of breast cancer.
O'Connell P; Fischbach K; Hilsenbeck S; Mohsin SK; Fuqua SA; Clark GM; Osborne CK; Allred DC
J Natl Cancer Inst; 1999 Aug; 91(16):1391-7. PubMed ID: 10451444
[TBL] [Abstract][Full Text] [Related]
38. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors.
Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834
[TBL] [Abstract][Full Text] [Related]
39. Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters.
Seitz S; Werner S; Fischer J; Nothnagel A; Schlag PM; Scherneck S
Eur J Cancer; 2000 Aug; 36(12):1507-13. PubMed ID: 10930798
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
